Genotyping HLA-B(superscript *) 1502 and Revised Drug Hazard Relief Act

Lin, GT(2011).Risk factors and management of mood stabilizer- associated Stevens-Johnson syndrome/Toxic Epidermal Necrolysis: a mini-review.Taiwanese Journal of Psychiatry.25,140-143.

Chen, P,Lin, J-J,Lu, C-S(2011).Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan.N Eng J Med.364,1126-1133.

Google Scholar

Gau, S S-F,Chao, P-F,Lin, Y-J,Chang, CJ,Gau, C-S(2008).The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study.J Clin Psychopharmacol.28,509-517.

Google Scholar

Lin, EH(2005)。The Study on Off-label Use of Carbamazepine。National Yang-Ming University。

Google Scholar

Phillips, EJ,Chung, W-H,Mockenhaupt,M,Roujeau, J-C,Mallal, SA(2011).Drug hypersensitivity: pharmacogenetics and clinical syndromes.J Allergy Clin Immunol.127,S60-66.

Google Scholar

國際替代計量

Genotyping HLA-B(superscript *) 1502 and Revised Drug Hazard Relief Act

全文下載

主題瀏覽

Genotyping HLA-B(superscript *) 1502 and Revised Drug Hazard Relief Act

基因標記HLA-B(上標 *)1502與藥害救濟法部分條文修正

參考文獻

延伸閱讀

國際替代計量

本網站使用Cookies